Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 19/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 13/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14267706 | 0.92 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14267696 | 0.90 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL1778535 | 0.88 | ADORA2B (0.78) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14267708 | 0.87 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL4759194 | 0.84 | ADORA2B (0.72) | ADORA2BADORA1ADORA2A | |
| SCHEMBL1780185 | 0.82 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL1780360 | 0.82 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14267728 | 0.82 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL1781336 | 0.81 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14267743 | 0.81 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335655-B2 | 8-heteroaryl xanthine adenosine A2B receptor antagonists | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-7335655-B2 | 8-heteroaryl xanthine adenosine A2B receptor antagonists | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-7205403-B2 | 8-Heteroaryl xanthine adenosine A2B receptor antagonists | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) | 2007-04-17 | — | — | US | disclosed |
| US-7205403-B2 | 8-Heteroaryl xanthine adenosine A2B receptor antagonists | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) | 2007-04-17 | — | — | US | disclosed |